Dividends Calendar Earnings Calendar

OCX | OncoCyte Corporation

Healthcare sector

OncoCyte Corporation

OCX Upgrades / Downgrades

Date Action Broker / Analyst Change Price Target
May 24, 2022DowngradeStephensOverweight → Equal-Weight
Jan 7, 2022InitiatedStephensOverweight $3.1
Jan 6, 2022ResumedPiper SandlerOverweight $3.1
Mar 17, 2021ResumedNeedhamBuy $8
Jan 7, 2021UpgradeThe Benchmark CompanySpeculative Buy → Buy$6
Dec 16, 2020UpgradePiper SandlerNeutral → Overweight$4
Nov 30, 2020InitiatedBTIG ResearchBuy $5
Nov 10, 2020InitiatedKeyBanc Capital MarketsOverweight $5
Jul 30, 2020ReiteratedThe Benchmark CompanySpeculative Buy $6
Jul 1, 2020DowngradePiper SandlerOverweight → Neutral
Jun 30, 2020DowngradeChardan Capital MarketsBuy → Neutral$2
Jun 2, 2020InitiatedNeedhamBuy $4
Feb 13, 2019InitiatedPiper JaffrayOverweight $6
Jan 29, 2019UpgradeJanneyNeutral → Buy
Dec 19, 2018ResumedLake StreetBuy


Jump to (Finance sites)

Google   
         

Their Official Profiles 

TwitterFacebookLinkedInYoutube

Other stocks 

apc rht wfc dltr lrcx tivo low intu mmyt xray ostk rh 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 




Recommended Books

The Intelligent Investor
Buy on Amazon

Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

The best book on investing ever written.
-- Warren Buffet